Purkiss Capital Advisors LLC Merck & Co., Inc. Transaction History
Purkiss Capital Advisors LLC
- $180 Billion
- Q2 2025
A detailed history of Purkiss Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Purkiss Capital Advisors LLC holds 4,626 shares of MRK stock, worth $388,213. This represents 0.2% of its overall portfolio holdings.
Number of Shares
4,626
Previous 2,682
72.48%
Holding current value
$388,213
Previous $241 Million
52.1%
% of portfolio
0.2%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,849Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...